{"nct_id":"NCT02038920","title":"Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease","status":"COMPLETED","status_verified_date":"2019-11","start_date":"2014-01-28","start_date_type":"ACTUAL","primary_completion_date":"2019-01-25","primary_completion_date_type":"ACTUAL","completion_date":"2019-05-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}